<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Bone</journal-id><journal-id journal-id-type="iso-abbrev">Bone</journal-id><journal-title-group><journal-title>Bone</journal-title></journal-title-group><issn pub-type="ppub">8756-3282</issn><issn pub-type="epub">1873-2763</issn><publisher><publisher-name>Elsevier Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26657825</article-id><article-id pub-id-type="pmc">4764652</article-id><article-id pub-id-type="publisher-id">S8756-3282(15)00420-2</article-id><article-id pub-id-type="doi">10.1016/j.bone.2015.11.019</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Full Length Article</subject></subj-group></article-categories><title-group><article-title>Multiscale alterations in bone matrix quality increased fragility in steroid induced osteoporosis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Karunaratne</surname><given-names>A.</given-names></name><email>a.karunaratne@imperial.ac.uk</email><xref rid="af0005" ref-type="aff">a</xref><xref rid="fn0005" ref-type="fn">1</xref></contrib><contrib contrib-type="author"><name><surname>Xi</surname><given-names>L.</given-names></name><email>l.xi@qmul.ac.uk</email><xref rid="af0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Bentley</surname><given-names>L.</given-names></name><email>l.bentley@har.mrc.ac.uk</email><xref rid="af0010" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Sykes</surname><given-names>D.</given-names></name><email>d.sykes@nhm.ac.uk</email><xref rid="af0015" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Boyde</surname><given-names>A.</given-names></name><email>a.boyde@qmul.ac.uk</email><xref rid="af0020" ref-type="aff">d</xref></contrib><contrib contrib-type="author"><name><surname>Esapa</surname><given-names>C.T.</given-names></name><email>c.esapa@har.mrc.ac.uk</email><xref rid="af0010" ref-type="aff">b</xref><xref rid="af0030" ref-type="aff">f</xref></contrib><contrib contrib-type="author"><name><surname>Terrill</surname><given-names>N.J.</given-names></name><email>nick.terrill@diamond.ac.uk</email><xref rid="af0025" ref-type="aff">e</xref><xref rid="af0035" ref-type="aff">g</xref></contrib><contrib contrib-type="author"><name><surname>Brown</surname><given-names>S.D.M.</given-names></name><email>s.brown@har.mrc.ac.uk</email><xref rid="af0010" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Cox</surname><given-names>R.D.</given-names></name><email>r.cox@har.mrc.ac.uk</email><xref rid="af0010" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Thakker</surname><given-names>R.V.</given-names></name><email>rajesh.thakker@ndm.ox.ac.uk</email><xref rid="af0030" ref-type="aff">f</xref></contrib><contrib contrib-type="author"><name><surname>Gupta</surname><given-names>H.S.</given-names></name><email>h.gupta@qmul.ac.uk</email><xref rid="af0005" ref-type="aff">a</xref><xref rid="cr0005" ref-type="corresp">&#x0204e;</xref></contrib></contrib-group><aff id="af0005"><label>a</label>Queen Mary University of London, School of Engineering and Material Science, Mile End Road, London E1 4NS, UK</aff><aff id="af0010"><label>b</label>MRC Mammalian Genetics Unit and Mary Lyon Centre, MRC Harwell, Harwell Science and Innovation Campus, OX11 0RD, UK</aff><aff id="af0015"><label>c</label>Core Research Laboratories, The Natural History Museum, London SW7 5BD, UK</aff><aff id="af0020"><label>d</label>Queen Mary University of London, Barts and the London School of Medicine and Dentistry, Institute of Dentistry, E1 2AD, UK</aff><aff id="af0025"><label>e</label>Diamond Light Source Ltd., Beamline I22, Diamond House, Harwell Science and Innovation Campus, Chilton, Didcot, Oxfordshire, OX11 0DE, UK</aff><aff id="af0030"><label>f</label>Academic Endocrine Unit, Nuffield Department of Clinical Medicine, Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), University of Oxford, Churchill Hospital, Headington, Oxford OX3 7JL, UK</aff><aff id="af0035"><label>g</label>Department of Chemistry, University of Sheffield, Dainton Building, Brookhill, Sheffield S3 7HF, UK</aff><author-notes><corresp id="cr0005"><label>&#x0204e;</label>Corresponding author at: School of Engineering and Materials Sciences, Queen Mary University of London, Mile End Road, London E1 4NS, UK.School of Engineering and Materials SciencesQueen Mary University of LondonMile End RoadLondonE1 4NSUK <email>h.gupta@qmul.ac.uk</email></corresp><fn id="fn0005"><label>1</label><p id="np0005">Present address: The Royal British Legion Centre For Blast Injury Studies, Department of Bioengineering, Imperial College London, London SW7 2AZ, UK.</p></fn></author-notes><pub-date pub-type="pmc-release"><day>1</day><month>3</month><year>2016</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.--><pub-date pub-type="ppub"><month>3</month><year>2016</year></pub-date><volume>84</volume><fpage>15</fpage><lpage>24</lpage><history><date date-type="received"><day>5</day><month>5</month><year>2015</year></date><date date-type="rev-recd"><day>30</day><month>10</month><year>2015</year></date><date date-type="accepted"><day>27</day><month>11</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; 2015 The Authors</copyright-statement><copyright-year>2015</copyright-year><license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><abstract><p>A serious adverse clinical effect of glucocorticoid steroid treatment is secondary osteoporosis, enhancing fracture risk in bone. This rapid increase in bone fracture risk is largely independent of bone loss (quantity), and must therefore arise from degradation of the quality of the bone matrix at the micro- and nanoscale. However, we lack an understanding of both the specific alterations in bone quality n steroid-induced osteoporosis as well as the mechanistic effects of these changes. Here we demonstrate alterations in the nanostructural parameters of the mineralized fibrillar collagen matrix, which affect bone quality, and develop a model linking these to increased fracture risk in glucocorticoid induced osteoporosis. Using a mouse model with an N-ethyl-N-nitrosourea (ENU)-induced corticotrophin releasing hormone promoter mutation (<italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup>) that developed hypercorticosteronaemia and osteoporosis, we utilized <italic>in situ</italic> mechanical testing with small angle X-ray diffraction, synchrotron micro-computed tomography and quantitative backscattered electron imaging to link altered nano- and microscale deformation mechanisms in the bone matrix to abnormal macroscopic mechanics. We measure the deformation of the mineralized collagen fibrils, and the nano-mechanical parameters including effective fibril modulus and fibril to tissue strain ratio. A significant reduction (51%) of fibril modulus was found in <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice. We also find a much larger fibril strain/tissue strain ratio in <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice (~&#x000a0;1.5) compared to the wild-type mice (~&#x000a0;0.5), indicative of a lowered mechanical competence at the nanoscale. Synchrotron microCT show a disruption of intracortical architecture, possibly linked to osteocytic osteolysis. These findings provide a clear quantitative demonstration of how bone quality changes increase macroscopic fragility in secondary osteoporosis.</p></abstract><abstract abstract-type="graphical"><title>Graphical abstract</title><fig id="f0040" position="anchor"><graphic xlink:href="fx1"/></fig></abstract><abstract abstract-type="author-highlights"><title>Highlights</title><p><list list-type="simple"><list-item id="u0005"><label>&#x02022;</label><p>In steroid induced osteoporosis, the mineralized collagen fibrils exhibit lower stiffness and a more random orientation distribution.</p></list-item><list-item id="u0010"><label>&#x02022;</label><p>Load induced reorientation at the fibrillar level is reduced in steroid induced osteoporosis compared to wild type.</p></list-item><list-item id="u0015"><label>&#x02022;</label><p>Reduced and more heterogeneous mineralization at the microscale was accompanied by significant increases in porosity.</p></list-item></list></p></abstract><kwd-group><title>Keywords</title><kwd>Glucocorticoid induced osteoporosis</kwd><kwd>In situ micro mechanical testing</kwd><kwd>Synchrotron small angle X-ray scattering</kwd><kwd>Nanoscale deformation mechanisms</kwd><kwd>Multiscale imaging</kwd></kwd-group></article-meta></front><body><sec id="s0005"><label>1</label><title>Introduction</title><p>Anti-inflammatory glucocorticoid treatments are mostly prescribed to an elderly population suffering from diverse disorders such as asthma, rheumatoid arthritis, immune diseases and following organ transplants <xref rid="bb0005" ref-type="bibr">[1]</xref>. However, glucocorticoid induced osteoporosis (GIOP), a form of secondary osteoporosis, is a clinically serious long term side effect of glucocorticoid treatment, resulting in loss in cancellous bone followed by cortical bone <xref rid="bb0010" ref-type="bibr">[2]</xref> and affecting 0.5% of the general population <xref rid="bb0015" ref-type="bibr">[3]</xref>. Osteoporotic fractures associated with glucocorticoid use occur in up to 30&#x02013;50% of patients on chronic glucocorticoid therapy <xref rid="bb0020" ref-type="bibr">[4]</xref>. Further, GIOP is the most notable clinical skeletal disorder where the established paradigm of using only bone quantity to predict fractures is clearly insufficient to explain increased fracture risk, as bone mineral density (BMD) measurements show no significant association with fractures. GIOP patients have greater risk of fracture at higher BMDs when compared to postmenopausal osteoporotic women <xref rid="bb0005" ref-type="bibr">[1]</xref>, <xref rid="bb0025" ref-type="bibr">[5]</xref>. It has been shown that glucocorticoid therapy affects both the amount of bone (bone quantity) as well as the micro-architecture and material level properties (local elastic modulus around osteocytes <xref rid="bb0030" ref-type="bibr">[6]</xref>, crystal orientation and the degree of mineralization <xref rid="bb0030" ref-type="bibr">[6]</xref>, <xref rid="bb0035" ref-type="bibr">[7]</xref> of the matrix) (bone quality) due to the down-regulation of bone-forming osteoblasts with concurrent alteration in the bone remodeling cycle <xref rid="bb0040" ref-type="bibr">[8]</xref>. Up to 40% reduction of both the mineral to matrix ratio and the elastic modulus (down to 14&#x000a0;GPa) was observed around osteocyte lacunae in <xref rid="bb0030" ref-type="bibr">[6]</xref>, along with 18% reductions in trabecular bone volume, 12% lower trabecular connectivity and 7% lower trabecular number as measured with microcomputed tomography. However, the mechanisms by which these micro- and nanoscale changes in bone material quality lead to increased fracture risk in GIOP are currently unknown.</p><p>Deformation mechanisms at multiple structural levels between the nano- and the microscale &#x02013; from the largest (osteons&#x000a0;~&#x000a0;200&#x000a0;&#x003bc;m in diameter) down to the smallest (tropocollagen molecules and carbonated apatite crystallites) &#x02013; lead to load-bearing bones achieving both a high stiffness and high work of fracture <xref rid="bb0045" ref-type="bibr">[9]</xref>, <xref rid="bb0050" ref-type="bibr">[10]</xref>, <xref rid="bb0055" ref-type="bibr">[11]</xref>, <xref rid="bb0060" ref-type="bibr">[12]</xref>. Bone quality changes occur initially at the smaller length scales, dictated by rates of formation of new basic multicellular units by osteoblasts, at level of lamellae (~&#x000a0;5&#x000a0;&#x003bc;m) and mineralized fibrils (~&#x000a0;200&#x000a0;nm). Alterations in the bone extracellular matrix induced by glucocorticoid therapy are downstream effects of altered cellular activity of bone cells in the pathological condition and may be involved in the reductions of the global mechanical competence of bone. However, a gap exists both in our knowledge of the structural changes in GIOP <xref rid="bb0030" ref-type="bibr">[6]</xref>, <xref rid="bb0035" ref-type="bibr">[7]</xref>, and more significantly in the relation between such structural changes at the bone material level and the increased macroscopic fragility in GIOP. Therefore, there is a clear need to apply high-resolution imaging techniques to close the gap between onset of fracture relevant changes and diagnosis. We hypothesize that enhanced fracture risk in GIOP is associated with nanomechanical alterations at the fibrillar level, which link into larger scale deformation mechanisms. Here, to test this hypothesis, we combine multi-scale imaging techniques and mechanical testing on an animal model of GIOP.</p><p>For the animal model for GIOP, a recently published mouse model of endogenous hypercorticosteronaemia (Cushing's syndrome) was used <xref rid="bb0065" ref-type="bibr">[13]</xref>, as the fracture risk associated with endogenous and exogenous GIOP have been shown to be similar <xref rid="bb0015" ref-type="bibr">[3]</xref>. The mouse model was generated via an N-ethyl-N-nitrosourea (ENU) induced mutation of the corticotrophin releasing hormone (<italic>Crh</italic>) promoter. The mutation, which involved a T-to-C transition at &#x02212;&#x000a0;120&#x000a0;bp within the <italic>Crh</italic> promoter, resulted in increased transcription activity, and <italic>in vivo</italic> assessment of <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice revealed them to have obesity, hypercorticosteronaemia, hyperglycaemia, and low bone mineral density (BMD) when compared to wild-type (WT) mice. <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice, when compared to WT mice, showed reduction in mineralizing surface area, mineral apposition rate, bone formation rate and osteoblast number; this was also accompanied by an increase in adipocytes in the bone marrow. These phenotypic changes validate the used of the <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice as a model for Cushing's syndrome and GIOP <xref rid="bb0065" ref-type="bibr">[13]</xref>.</p><p>In this study, the alterations in fibrillar-level deformability, mineralization and cortical micro-architecture in GIOP can thus be quantified and linked to macroscale mechanical properties using <italic>in situ</italic> X-ray nanomechanical imaging <xref rid="bb0070" ref-type="bibr">[14]</xref>, <xref rid="bb0075" ref-type="bibr">[15]</xref> synchrotron micro-computed tomography and scanning electron microscopic investigations respectively.</p></sec><sec id="s0010"><label>2</label><title>Material and methods</title><sec id="s0015"><label>2.1</label><title>Study design and cohort</title><p><italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice were identified in a dominant ENU mutagenesis screen at the MRC MGU Harwell <xref rid="bb0065" ref-type="bibr">[13]</xref>. Female <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice on a C57BL/6 genetic background (third generation) were used in all experiments; littermate WT mice were used as controls. Animals were 26&#x000a0;weeks of age at the time of sacrifice. Animals were anaesthetised before cervical dislocation; internal organs were removed from the body cavity and the whole body skeleton stored at &#x02212;&#x000a0;20&#x000a0;&#x000b0;C until used.</p></sec><sec id="s0020"><label>2.2</label><title>Backscattered scanning electron (BSE) imaging</title><p>Quantitative BSE (qBSE) imaging was performed on transverse cross section at the mid-diaphysis to determine the microscale degree of mineralization. Mice femora (<italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup>&#x000a0;=&#x000a0;5 and WT&#x000a0;=&#x000a0;5) were sectioned into halves using a low speed diamond saw before dehydrating in ethanol and embedding in poly-methyl-methacrylate (PMMA) <xref rid="bb0080" ref-type="bibr">[16]</xref>, <xref rid="bb0085" ref-type="bibr">[17]</xref>. Digital BSE imaging was performed with an Inspect-F, FEI scanning electron microscope equipped with an annular solid state BSE detector. The electron beam was adjusted to 20&#x000a0;kV accelerating voltage and 160&#x000a0;&#x003bc;A sample current was used to perform the analytical imaging. The working distance in the SEM was adjusted to 15&#x000a0;mm. The pixel resolution of the Digital BSE images from the midshaft transverse cross section was 0.3125&#x000a0;&#x003bc;m 1024&#x000a0;&#x000d7;&#x000a0;943 pixels) with gray level resolution of 256. These gray levels values were converted into calcium weight% values using carbon and aluminum (Micro-Analysis Consultants Ltd., Cambridgeshire UK) as gray level references. In <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice bone, two distinct regions (cavity region in the endosteal cortex and periosteal cortex) were observed. Three (WT) to six (<italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup>: 3 from endosteal cortex and 3 from periosteal cortex) regions of interest (50&#x000a0;&#x000d7;&#x000a0;50&#x000a0;&#x003bc;m) from each BSE image (<italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup>&#x000a0;=&#x000a0;5 and WT&#x000a0;=&#x000a0;5) of the anterior transverse cortex were used to produce the grey level histograms. Using BMDD histograms, the mean calcium weight percentage Ca<sub>mean</sub> and full width at half maximum (FWHM) <xref rid="bb0090" ref-type="bibr">[18]</xref> were calculated.</p></sec><sec id="s0025"><label>2.3</label><title>Synchrotron X-ray computed tomography</title><p>Synchrotron radiation microCT was performed at the imaging beam line I13-2 at Diamond Light Source (Harwell, UK) to visualize the vascular canal network. Three tibiae specimens from three WT mice and three tibiae from three <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice were oriented with their longitudinal axis parallel to the rotation axis during scanning. The effective voxel size was 1.6&#x000a0;&#x003bc;m<sup>3</sup>, providing a spatial resolution of 3.2&#x000a0;&#x003bc;m and field of view of 4.2&#x000a0;&#x000d7;&#x000a0;3.5&#x000a0;&#x003bc;m. Tomographic scans were obtained using photon energy of 18&#x000a0;keV and exposure time was 0.1&#x000a0;s. For each 3D data set, a total of 3600 projections were acquired over a range of 180&#x000b0;. The Diamond Light Source in-house algorithm was used to reconstruct tomographic data and 3D volumetric visualization of tibiae mid diaphysis was created by segmentation tools in Avizo 3D software (Burlington, MA, USA). Image volumes at the mid diaphysis of 1.35&#x000a0;&#x000d7;&#x000a0;1.34&#x000a0;&#x000d7;&#x000a0;1.00&#x000a0;mm<sup>3</sup> were used for further morphometric analysis. Using Aviso intracortical cortical lacunae and canals were segmented from dense cortical tissue with simple thresholding due to their densities being significantly different, and this also provided volume measurements of the bone. STL meshes were created for segmented volumes (lacunae and canals) and imported into Blender software (Blender Foundation, Amsterdam, Netherlands) where it was separated by loose parts (unconnected mesh components) to give a total count of lacunae, canals and artefacts. The artifacts largely occurred outside the bone so could be selected, isolated and counted in Blender (using the same method as above). The mesh was then imported into Meshlab (<ext-link ext-link-type="uri" xlink:href="http://meshlab.sourceforge.net" id="ir0005">http://meshlab.sourceforge.net</ext-link>/) where components less than 1% of the total mesh size were removed with the &#x0201c;remove isolated components (with respect to diameter) algorithm&#x0201d; leaving mainly the canals which could then be manually counted. Both the artefact and canals counts were then subtracted from the total count to give the lacunae number. We derived morphometric measures for female <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> and wild-type littermates, including lacunae number density (number of lacunae/cortical tissue volume) and canal number density (number of lacunae/cortical tissue volume).</p></sec><sec id="s0030"><label>2.4</label><title>Sample preparation for <italic>in situ</italic> tensile testing with SAXD</title><p>Mouse femora (<italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup>&#x000a0;=&#x000a0;6 and WT&#x000a0;=&#x000a0;4) from female <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> and wild-type littermates were dissected, skinned and muscle tissue removed. Then the bones were systematically prepared <xref rid="bb0085" ref-type="bibr">[17]</xref> for in-situ tensile testing (see Supplementary information for full detail). Bone strips only from anterior sections of the femora were used in this experiment such that long axis of specimens are parallel to the femur. The average length, width and thickness of the gauge regions were 5.0&#x000a0;mm, 1.0&#x000a0;mm and 0.2&#x000a0;mm, respectively.</p></sec><sec id="s0035"><label>2.5</label><title>In-situ tensile loading with small angle X-ray scattering</title><p>Samples were loaded at a constant velocity of 1&#x000a0;&#x003bc;m/s (strain rate&#x000a0;=&#x000a0;0.02%/s) in a custom-made micromechanical testing machine <xref rid="bb0085" ref-type="bibr">[17]</xref> in the path of a microfocus synchrotron X-ray beam at beamline I22, Diamond Light Source (Harwell, UK). A schematic of the experimental setup is shown in Fig. S1 (Supplementary data). Samples were maintained in physiological saline in a fluid chamber and strained at 10<sup>&#x02212;&#x000a0;4</sup>&#x000a0;s<sup>&#x02212;&#x000a0;1</sup>, with SAXD spectra taken every 0.05% tissue strain up to failure (~&#x000a0;0.5&#x02013;1.0%). X-ray wavelength &#x003bb; was 0.8857&#x000a0;&#x000c5; and beam cross section 10&#x000a0;&#x003bc;m&#x000a0;&#x000d7;&#x000a0;12&#x000a0;&#x003bc;m. Sample to detector distance was 1.034&#x000a0;m, measured with a calibration standard (type I collagen). During the experiment, exposure time for each SAXD spectra was kept to approximately 1&#x000a0;s, limiting the total X-ray radiation dosage to 29.4&#x000a0;kGy to minimise the influence of the X-ray radiation on the bone mechanical properties <xref rid="bb0095" ref-type="bibr">[19]</xref>. The collagen fibril strain &#x003b5;<sub>f</sub> was measured from change of the centre position <italic>q</italic><sub>0</sub> of the third order reflection peak, as described previously <xref rid="bb0070" ref-type="bibr">[14]</xref>, <xref rid="bb0075" ref-type="bibr">[15]</xref>, <xref rid="bb0100" ref-type="bibr">[20]</xref>. 2D SAXD patterns were reduced to one dimensional profiles by radial integration over a 20&#x000b0; sector oriented parallel to the tensile loading axis (Fig. S1). Subsequently, the third-order meridional fibrillar reflections were fitted to Gaussians with a linear background term obtain peak position <italic>q</italic><sub>0</sub>. Axial fibrillar periodicity <italic>D</italic>&#x000a0;=&#x000a0;6<italic>&#x003c0;</italic>&#x000a0;/&#x000a0;<italic>q</italic><sub>0</sub>, and fibril strain equals the percentage increases in D relative to the unstressed state. Tissue strain was measured by non-contact video extensometry of displacement of horizontal optical markers (Fig. S1C inset i) on the bone mid diaphysis. We consider only the elastic regime of bone deformation in this paper, and hence only data collected from the linear region was used for further analysis. The elastic region for each sample was identified using the baseline of &#x0003e;&#x000a0;10% reduction the slope of the stress strain curve, shown in Fig. S2 in supplementary information.</p></sec><sec id="s0040"><label>2.6</label><title>Degree of fibrillar orientation</title><p>To determine the degree of orientation of the collagen fibrils with respect to the loading axis, the full width at half maximum of the meridional 3rd order reflection I<sub>c</sub>(&#x003c7;) was estimated from unstrained samples. To eliminate mineral scattering background in SAXD, the total azimuthal intensity I(&#x003c7;;<italic>q</italic><sub>0</sub>) at <italic>q</italic>&#x000a0;=&#x000a0;<italic>q</italic><sub>0</sub> and the azimuthal distribution of mineral-scattering I<sub>m;c</sub>(&#x003c7;;<italic>q</italic>&#x000a0;=&#x000a0;&#x000b1;&#x000a0;5)were calculated. I(&#x003c7;; <italic>q</italic><sub>0</sub>) was calculated by radially averaging the SAXD intensity in a narrow band around <italic>q</italic><sub>0</sub>. I<sub>m;c</sub>(&#x003c7;) was similarly calculated by averaging I(&#x003c7;) at wave-vectors lower <italic>q</italic><sub>l</sub> and higher <italic>q</italic><sub><italic>h</italic></sub> (Fig. S1D a and c) than <italic>q</italic><sub>0</sub> (Fig. S1D b). I<sub>c</sub>(&#x003c7;) is the difference between I(&#x003c7;;<italic>q</italic><sub>0</sub>) and I<sub>m;c</sub>(&#x003c7;;<italic>q</italic>&#x000a0;=&#x000a0;&#x000b1;&#x000a0;5). The angular intensity of the 3rd order fibril reflection I<sub>c</sub>(&#x003c7;) is plotted in Fig. S1F. The intensity was fitted to a Gaussian function I(&#x003c7;)&#x000a0;=&#x000a0;I<sub>0</sub> exp(&#x02212;((&#x003c7;&#x000a0;&#x02212;&#x000a0;&#x003c7;<sub>0</sub>)&#x000a0;/&#x000a0;&#x00394;&#x003c7;<sub>0</sub>)<sup>2</sup>&#x000a0;/&#x000a0;2), where &#x003c7;<sub>0</sub> is the centre of the intensity distribution and &#x00394;&#x003c7;<sub>0</sub> proportional to the width (FWHM). The average rates of collagen fibrillar reorientation were determined for WT&#x000a0;=&#x000a0;4 and <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup>&#x000a0;=&#x000a0;6 by calculating the slopes of FWHM vs. tissue strain curves.</p></sec><sec id="s0045"><label>2.7</label><title>Statistical analysis</title><p>To compare nanomechanical and synchrotron X-ray micro-computed tomography results between WT and <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice, Student t-tests were performed. One way ANOVA test with post-hoc Tukey HSD test was performed on mean calcium weight percentage Ca<sub>mean</sub> and full width at half maximum (FWHM) data to assess statistical significance between periosteal and endosteal regions of <italic>Crh</italic><sup>-120/+</sup> mice and their WT littermates. Excel 2007 (Microsoft Office 2007) was used for the Student t-test, ANOVA and post-hoc Tukey HSD test.</p></sec></sec><sec id="s0050"><label>3</label><title>Results</title><sec id="s0055"><label>3.1</label><title>BSE Imaging and quantitative analysis</title><p>Backscattered scanning electron microscopy (BSE) was performed on femoral transverse cross sections to examine possible mineralization defects in <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice. Cortical microstructure of the <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice (<xref rid="f0005" ref-type="fig">Fig. 1</xref>B) femora was markedly different to the WT mice (<xref rid="f0005" ref-type="fig">Fig. 1</xref>A) cortical structure. BSE images of femoral transverse cross-sections of WT mice showed a uniform cortical thickness, whereas in the <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice, the posterior cortex was substantially thinner compared to the anterior cortex. The anterior, lateral and medial cross sections of <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> femora had a very large fraction of cavities. In contrast, WT femoral bone was uniformly dense around the full cortex. High magnification BSE images (<xref rid="f0005" ref-type="fig">Fig. 1</xref>A bottom) of the WT cortex show uniformly distributed lacunae. However, in <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup>&#x000a0;mice osteocytic area is low compared to WT mice. Strikingly, <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice cortices had numerous localized cement lines surrounding low mineralized tissue (<xref rid="f0005" ref-type="fig">Fig. 1</xref>B, lower image, (i)) near cavities, which were absent in WT cortices. These structures were ~&#x000a0;50&#x000a0;&#x000d7;&#x000a0;50&#x000a0;&#x003bc;m in area, surrounded a significant number of osteocytes and localized to the endosteal cortex.</p><p>Bone mineralization density distribution (BMDDs) histograms (<xref rid="f0010" ref-type="fig">Fig. 2</xref>A) were plotted for <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> and WT femoral transverse cross-sections. Since we observed very distinct intra-tissue (regions surrounded by the localized cement lines) variation of mineralization on the <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice femora as reported above, both regions (<xref rid="f0005" ref-type="fig">Fig. 1</xref>Bi and ii) were used separately for quantitative BSE analysis. <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice showed a lowered average mineral content compared to WT (<xref rid="f0005" ref-type="fig">Fig. 1</xref>B). Mean calcium weight percentage (Ca<sub>mean</sub>) was lowest at regions (area surrounded by the cement lines) near the cavities in <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice (27.06&#x000a0;&#x000b1;&#x000a0;1.18 S.D. (<xref rid="f0010" ref-type="fig">Fig. 2</xref>B), and significantly greater in the cortical periosteum (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01) at the regions away from cavities (28.44&#x000a0;&#x000b1;&#x000a0;0.84&#x000a0;S.D.) (<xref rid="f0005" ref-type="fig">Fig. 1</xref>Bii). WT mice (30.32%&#x000a0;&#x000b1;&#x000a0;1.09 S.D.) had significantly higher (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01 for both WT vs. regions near and away from cavities in <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice) Ca<sub>mean</sub> compared to <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice. The homogeneity of tissue-level mineralization (FWHM) was highest at regions around cavities (6.43&#x000a0;&#x000b1;&#x000a0;1.30 S.D.) in <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice (<xref rid="f0010" ref-type="fig">Fig. 2</xref>C), and substantially lower in regions near the periosteal surfaces (4.63&#x000a0;&#x000b1;&#x000a0;0.73 S.D.) away from the cavities. In contrast to <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice bones, WT mice had significantly lower (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01) FWHM (3.80&#x000a0;&#x000b1;&#x000a0;1.02 S.D.).</p></sec><sec id="s0060"><label>3.2</label><title>Synchrotron X-ray micro-computed tomography</title><p>In order to gain better understanding of 3D distribution of cavities and micro structure of cortical bone, synchrotron X-ray micro tomography imaging was carried out. Results presented in <xref rid="f0015" ref-type="fig">Fig. 3</xref>C and D show most of these cavities (red; color online) are localized into the anterior cortico-endosteal bone along the tibiae shaft. These localized cavities are not present in WT mice. 3D reconstructions of vascular canal network and lacunae (segmented with yellow color; color online) presented in <xref rid="f0015" ref-type="fig">Fig. 3</xref>B show that WT and <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> bones have individual canals directly connected to the medullary cavity. However, WT bone exhibited very condensed network of canals and osteocyte lacunae homogenously distributed across the cortical bone. In contrast, in <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice most of the canal network and lacunae space have been replaced by cavities (<xref rid="f0015" ref-type="fig">Fig. 3</xref>B and C). Morphometric evaluation on vascular canals and osteocyte lacunae are shown in <xref rid="f0020" ref-type="fig">Fig. 4</xref>A and B respectively. These results indicated a significant reduction in canal density (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05) and lacunae density (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.001) in <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice bones. Average volume fractions for porous sections (red segmented sections in <xref rid="f0015" ref-type="fig">Fig. 3</xref>) and residual regions (purple segmented sections in <xref rid="f0015" ref-type="fig">Fig. 3</xref>)) are 0.025 and 0.0083 respectively. In contrast, in WT mice no such structures were observed.</p><p>Furthermore, <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice bones exhibits some unmineralized tissue (<xref rid="f0015" ref-type="fig">Fig. 3</xref>A and segmented with purple color in <xref rid="f0015" ref-type="fig">Fig. 3</xref>B, C and D; color online) within the medullary cavity attached to the cortico-endosteal bone. This tissue has lower gray value (lower mineral content) compared to the cortical bone of <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice. The increased cavity structure (red voids; color online) in <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice bone is present across the entire length of the bone shaft, as evidenced from synchrotron X-ray microCT measurements across the entire mid-diaphysis (Supplementary <xref rid="ec0010" ref-type="supplementary-material">Video S1</xref>, <xref rid="ec0015" ref-type="supplementary-material">Video S2</xref>).</p></sec><sec id="s0065"><label>3.3</label><title><italic>In situ</italic> tensile loading with synchrotron SAXD</title><p>Tissue level and fibrillar and mechanics of cortical bone from femoral mid-diaphyses of 26&#x000a0;week old WT (n&#x000a0;=&#x000a0;4) and <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> (n&#x000a0;=&#x000a0;6) mice were measured using <italic>in situ</italic> micro mechanical tensile testing combined with microfocus SAXD. Porosity-corrected stress versus tissue strain was plotted (<xref rid="f0025" ref-type="fig">Fig. 5</xref>A) as a function of genotype. Tissue level elastic moduli are significantly (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05) lower in <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice compared to WT mice (<xref rid="f0025" ref-type="fig">Fig. 5</xref>A inset). Average yield stress (<xref rid="f0025" ref-type="fig">Fig. 5</xref>B) of the WT mice (28.2&#x000a0;MPa&#x000a0;&#x000b1;&#x000a0;7.1 S.D.) is significantly larger compared to <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice (16.2&#x000a0;MPa&#x000a0;&#x000b1;&#x000a0;7.3 S.D.). Tissue yield strain of <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice was not significantly different (<italic>p</italic>&#x000a0;&#x0003e;&#x000a0;0.05) from WT mice (<xref rid="f0025" ref-type="fig">Fig. 5</xref>C).</p><p>Considering the fibrillar-level deformation, the gradient of stress versus fibril strain (<xref rid="f0030" ref-type="fig">Fig. 6</xref>A) in the elastic regime is denoted as the effective fibril modulus (E<sub>f</sub>&#x000a0;=&#x000a0;d&#x003c3;&#x000a0;/&#x000a0;d&#x003b5;<sub>f</sub>), as per our previous definition <xref rid="bb0085" ref-type="bibr">[17]</xref>. Average fibril modulus (<xref rid="f0030" ref-type="fig">Fig. 6</xref>B) shows a significant (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05) reduction of ~&#x000a0;79% in <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> bone relative to WT. To calculate the fraction of tissue strain taken up at fibrillar level <xref rid="bb0075" ref-type="bibr">[15]</xref>, fibril strain was plotted against macroscopic strain (<xref rid="f0030" ref-type="fig">Fig. 6</xref>C). Gradients of fibril strain (&#x003b5;<sub>F</sub>) versus tissue strain (&#x003b5;<sub>T</sub>) are clearly different (<xref rid="f0030" ref-type="fig">Fig. 6</xref>D), with the d&#x003b5;<sub>F</sub>/d&#x003b5;<sub>T</sub> much higher in <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> mice compared to WT (1.18&#x000a0;&#x000b1;&#x000a0;0.43) compared to 0.57&#x000a0;&#x000b1;&#x000a0;0.2 S.D.) Maximal fibril strain for <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> specimens (0.63%&#x000a0;&#x000b1;&#x000a0;0.22 S.D.) was significantly higher (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05) compared to WT mice (0.3%&#x000a0;&#x000b1;&#x000a0;0.25 S.D.) (Data not shown).</p><p>The degree of fibrillar orientation (FWHM) between WT and <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> mice at unloaded state was significantly (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01) higher compared to WT, indicating a lesser degree of fibrillar alignment relative to the tensile axis (<xref rid="f0030" ref-type="fig">Fig. 6</xref>E). The load-induced fibrillar reorientation, the percentage change in fibrillar orientation (from the unloaded state for each sample) for WT and <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> mice shows the resultant change, indicating that the fibrillar orientation reduces for all samples (<xref rid="f0030" ref-type="fig">Fig. 6</xref>F), but is much less pronounced than <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> mice relative to WT mice. Rate of fibrillar reorientation with fibrillar deformation in <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> mice is significantly lower (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05) compared to WT mice.</p></sec></sec><sec id="s0070"><label>4</label><title>Discussion</title><p>Here, we have applied a combination of nano- and microscale structural and mechanical probes to quantify the mechanisms by which bone material quality changes in a mouse model of GIOP <xref rid="bb0065" ref-type="bibr">[13]</xref> leads to increased macroscopic fragility. Glucocorticoid-induced osteoporosis <xref rid="bb0105" ref-type="bibr">[21]</xref>, <xref rid="bb0110" ref-type="bibr">[22]</xref> is an especially appropriate osteoporosis model to clarify the mechanistic role of bone quality, as it is well-established (e.g. in postmenopausal women <xref rid="bb0115" ref-type="bibr">[23]</xref>) that the steroid-increased increase of fracture risk appears uncorrelated to changes in bone quantity. Nonetheless, while cellular changes in bone metabolism have been identified in GIOP <xref rid="bb0010" ref-type="bibr">[2]</xref>, <xref rid="bb0030" ref-type="bibr">[6]</xref>, less is known about the alterations in bone material <xref rid="bb0120" ref-type="bibr">[24]</xref>, <xref rid="bb0125" ref-type="bibr">[25]</xref>, and very little about the altered deformation mechanisms of the bone material in GIOP. We used X-ray nanomechanical imaging techniques combined with micro-structural probes of mineral content and 3D microarchitecture to provide a quantitative link between structure at the nano- and microscale and the mechanical quality deterioration in a mouse model for Cushing's syndrome, with relevance for GIOP.</p><p>While the mouse model used in this study exhibits endogenous steroid production characteristic of Cushing's syndrome <xref rid="bb0065" ref-type="bibr">[13]</xref>, which is in contrast to the usual etiology of GIOP where steroids are administered exogenously as part of anti-inflammatory medication <xref rid="bb0005" ref-type="bibr">[1]</xref>, there are sufficient similarities to make it a worthwhile comparison. The <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> mice in this study have been previously shown <xref rid="bb0065" ref-type="bibr">[13]</xref> to exhibit osteoporosis, specifically showing reduced bone formation, number of osteoblasts, mineral apposition rate, and fraction of the endosteal surface of cortical bone which was covered by osteoblasts. Further, an increased adipocyte concentration in <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> mice <xref rid="bb0090" ref-type="bibr">[18]</xref> suggest that bone marrow stromal cells preferentially differentiate to adipocytes rather than osteoblasts, as seen in GIOP <xref rid="bb0055" ref-type="bibr">[11]</xref>, <xref rid="bb0130" ref-type="bibr">[26]</xref> In addition, atomic force microscopy and other imaging methods have shown <xref rid="bb0030" ref-type="bibr">[6]</xref>, <xref rid="bb0120" ref-type="bibr">[24]</xref>, <xref rid="bb0135" ref-type="bibr">[27]</xref> that GIOP cortical murine bone exhibits &#x0201c;haloes&#x0201d; of lesser mineralized tissue around osteocyte lacunae. Similar microstructural alterations are observed in the current mouse model as well as significantly altered 3D microstructural architecture, which gives confidence that the alterations in bone matrix mechanics and structure visible here are relevant to the case of GIOP. As discussed earlier <xref rid="bb0065" ref-type="bibr">[13]</xref>, the current model can hence be considered a complement to existing models of exogenously induced GIOP <xref rid="bb0010" ref-type="bibr">[2]</xref>, <xref rid="bb0140" ref-type="bibr">[28]</xref>, <xref rid="bb0145" ref-type="bibr">[29]</xref> with special application to understanding the longer-term effects of GIOP on bone structure and quality, in line with the continuous production of steroids over the lifetime of the animal.</p><p>The main findings of our study can be summarized as follows:<list list-type="simple"><list-item id="u0020"><label>&#x02022;</label><p>Nanoscale mechanical alterations: We observed a reduced fibril modulus, increased fibrillar extensibility, increased randomness of fibril texture and reduced rate of fibrillar reorientation in the cortical bone of <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> mice subjected to tensile loading, compared to WT controls</p></list-item><list-item id="u0025"><label>&#x02022;</label><p>Microscale material and structural alterations: A reduced average mineral content and increased heterogeneity of mineralization were accompanied by significant increases in porosity and alterations in 3D microarchitecture, presence of lower mineralized tissue around these pores and disrupted endosteal structure in the cortices of <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> mice compared to WT controls.</p></list-item><list-item id="u0030"><label>&#x02022;</label><p>Macromechanical changes: The tissue-level stiffness reduced, the maximum tissue strain increased and the breaking stress reduced also reduced in the bones of <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> mice compared to WT controls.</p></list-item></list></p><p>In the following, we will discuss these findings, and their relation to existing knowledge about the alteration of bone structure in GIOP as well as in related disorders like Cushing's syndrome in more detail.</p><p>At the microstructural level, the microCT images indicate substantial, interconnected pores inside the cortex of bones, which is accompanied by the reduction in mineralization of the remaining matrix. The open question is whether this difference is the product of disrupted endosteal structure, or due to the presence of blood vessels inside these cavities, leading to Haversian-type remodelling with secondary tissue formation. From prior histochemical studies of this model <xref rid="bb0065" ref-type="bibr">[13]</xref>, it is found that due to a combination of reduced osteoblast coverage on the cortico-endosteal surface, a lower mineralizing rate and lower overall number of osteoblasts, the endosteal surface develops with a ruffled, porous surface characteristic of cancellous bone, which are the large voids visualized by our microCT data. Further, there is no direct evidence of blood vessels inside these cavities from microscopy or SEM images, suggesting that secondary remodelling may not be playing a role. Thus, the first possibility is more likely. However, it should be noted that osteocytes inside already formed cortical bone have been proposed to be capable of resorbing formed bone (osteocytic osteolysis) by leaching and proteolytic process of osteocytes <xref rid="bb0030" ref-type="bibr">[6]</xref>, <xref rid="bb0150" ref-type="bibr">[30]</xref>, <xref rid="bb0155" ref-type="bibr">[31]</xref>, <xref rid="bb0160" ref-type="bibr">[32]</xref>. While this view is contested <xref rid="bb0165" ref-type="bibr">[33]</xref> it is possible that enhanced removal of endocortical bone tissue by osteocytic osteolysis activated in GIOP <xref rid="bb0030" ref-type="bibr">[6]</xref>may also be a causative factor behind the large voids and cavities found, and at present we cannot conclusively exclude either possibility. The microstructure of the tissue toward the endosteal surface exhibit regions of low overall mineralization (<xref rid="f0010" ref-type="fig">Fig. 2</xref>B), which bear some resemblance to the lowered mineralized haloes observed in GIOP bone in <xref rid="bb0030" ref-type="bibr">[6]</xref>, and also show some highly mineralized thin lines at their peripheries. The low mineralized zones also have a more heterogeneous distribution, as characterized by the larger FWHM in BMDD results (<xref rid="f0010" ref-type="fig">Fig. 2</xref>C). The overall reduction in mineral content and the increased heterogeneity in <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> (<xref rid="f0005" ref-type="fig">Fig. 1</xref>) may be linked to the adverse effect of glucocorticoid treatment on cellular activities.</p><p>Synchrotron X-ray microtomography data demonstrated that cavities are interconnected to each other along the longitudinal direction of the tibiae in <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> mice. Furthermore this 3D representation (<xref rid="f0015" ref-type="fig">Fig. 3</xref> qualitatively) and morphometric evaluation (<xref rid="f0020" ref-type="fig">Fig. 4</xref>) showed that the <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> bones has reduced proportion of normal vascular network and less density of osteocyte lacunae compared to WT cortical bone. However, a much larger fraction of intracortical cavities are found, unique to <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> mice, which may be the late-stage result of enhanced osteocytic osteolysis inside the cortical shell <xref rid="bb0030" ref-type="bibr">[6]</xref>, <xref rid="bb0120" ref-type="bibr">[24]</xref>, <xref rid="bb0155" ref-type="bibr">[31]</xref>, <xref rid="bb0160" ref-type="bibr">[32]</xref>. These findings are less apparent when investigating 2D-only images such as BSE imaging. Quantitative analysis of 3D morphological analysis such as canals density and lacuna density was performed in this study. Despite the limitation of small (3) number of samples capable of being measured in the limited synchrotron time, qualitatively and quantitatively significant differences in microstructure was observed between <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> and WT mice.</p><p>In terms of bone matrix mechanics, we observed significantly reduced (~&#x000a0;50%) elastic modulus (<xref rid="f0025" ref-type="fig">Fig. 5</xref>A) and strength (<xref rid="f0025" ref-type="fig">Fig. 5</xref>B) in the femora of GIOP-exhibiting <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> mice at the macroscopic scale, which remain significant after correcting for elevated microstructural porosity in <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> (WT 2% and <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> 30%; Fig. S2). However, the origin of the material-level changes causing this mechanical deterioration may lie at either or both the micro (lamellar) and the ultrastructural length scale in the structural hierarchy. We find evidence that reduced stiffness at the fibrillar level plays an important role in this mechanical deterioration: the effective fibril moduli (&#x003c3;/&#x003b5;<sub>F</sub>) in <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> mice are significantly (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05) less stiff (~&#x000a0;75%) than controls (<xref rid="f0030" ref-type="fig">Fig. 6</xref>A and B). We speculate that the alterations could be due to the reduced stiffness in extrafibrillar environment in <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> tissue. In the linearly elastic region of deformation (<xref rid="f0025" ref-type="fig">Fig. 5</xref>A), the externally applied tensile strain can to be divided into a tensile stretching of the mineralized collagen fibril together with deformation at larger length scales, which may include shear in the extrafibrillar matrix between fibrils <xref rid="bb0170" ref-type="bibr">[34]</xref> or between lamellae. Our <italic>in situ</italic> SAXD results show (<xref rid="f0030" ref-type="fig">Fig. 6</xref>C) that because the fibril modulus is lower, the maximum deformation in the mineralized fibrils in <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> is significantly higher (up to ~&#x000a0;0.63%) relative to WT (up to ~&#x000a0;0.3%).</p><p>The fibril-strain/tissue-strain ratio in the WT mineralized collagen fibrils is ~&#x000bd; (<xref rid="f0030" ref-type="fig">Fig. 6</xref>D), consistent with previous <italic>in situ</italic> SAXD on bovine fibrolamellar bone, but in contrast, the fibril-to-tissue strain ratio for <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> bone is ~&#x000a0;1, within experimental error. While an increase in fibril-strain/tissue-strain ratio in well-oriented bovine fibrolamellar bone was earlier explained by us <xref rid="bb0075" ref-type="bibr">[15]</xref> as due to increased mineralization in the extrafibrillar compartment, this mechanism clearly cannot hold for the osteoporotic <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> mice, because they exhibit significant reduction in degree of mineralization (<xref rid="f0010" ref-type="fig">Fig. 2</xref>B). As the fibril orientation distribution (reflecting lamellar level architecture) is significantly more random in <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> than in WT (<xref rid="f0030" ref-type="fig">Fig. 6</xref>E), we conclude that microscale inhomogeneity in lamellar level fibril orientation in <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> may be playing a significant role in the altered fibril-strain/tissue-strain ratio as well as in the altered macroscale mechanics. The alterations of macroscopic mechanics with fibril orientation is consistent with a recent study showing that microfibril orientation dominates the local elastic properties of lamellar bone <xref rid="bb0175" ref-type="bibr">[35]</xref>, The alteration in fibril-strain/tissue strain ratio is quite consistent with the highly porous, heterogeneous mineralized matrix observed in <xref rid="f0005" ref-type="fig">Fig. 1</xref>B. In such a system, the local tissue strain (distinct from the global tissue strain &#x003b5;<sub>T</sub>) in the more randomly oriented fibrils in <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> mice will be different when compared with WT mice.</p><p>Our results show (<xref rid="f0030" ref-type="fig">Fig. 6</xref>F) that the mineralized fibrils in both groups undergo a reduction in degree of fibrillar orientation on loading, which corresponds physically to a stress-induced alignment of the fibrils toward the loading axis. However, the rate of the fibrillar reorientation is different between <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> and WT with a significantly lower rate of reorientation in <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> mice. Prior to discussing these differences, however, the magnitudes of the changes in the width of the fibril angular distribution (<xref rid="f0030" ref-type="fig">Fig. 6</xref>F) deserve comment. For tissue strains of ~&#x000a0;1&#x02013;2% (and equivalent fibril strains of ~&#x000a0;0.5&#x02013;1%) we observe much larger percentage changes in the width, of the order of 10&#x02013;20%. At first glance this finding of relatively large reduction in the width is a very surprising result, as it is expected that the percentage change of the angular distribution will be comparable to the percentage change of the fibrillar elongation, and not much larger. It is important to note that the large angular change is not related to the disease-phenotype &#x02014; both WT and <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> specimens have comparable order of magnitude effects, and the <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> reorientation is actually lower (<xref rid="f0030" ref-type="fig">Fig. 6</xref>F). In order to exclude artefacts from our data analysis, we took special care to fit the angular intensity profile to a Gaussian without a baseline as we found (data not shown) that the introduction of an artificial baseline significantly affected (reduced) the width of the peak of the remaining Gaussian, and as a result the percentage reductions were even larger. Further, we kept the meridional width of the 3rd order reflection (used for radial averaging) large enough such that all the intensity in the peak was averaged, not just the intensity along the meridional peak position. Lastly (data not shown), to exclude the possibility that this large change was a characteristic of our mouse bone cortical specimen preparation protocol, a comparable analysis of the percentage change in fibril width for standard tissue types like the bovine fibrolamellar bone and antler cortical tested by us previously <xref rid="bb0100" ref-type="bibr">[20]</xref> show similarly large reductions of the order of ~&#x000a0;10% for strains &#x0003c;&#x000a0;1%. We can therefore say with confidence that this effect is a real one which is characteristic of cortical bone of various types in our samples.</p><p>In order to explain this large reduction, we need to consider the local loading environment of the fibril. If we assume (incorrectly, as it will turn out) that the fibrils and surrounding interfibrillar matrix are in an strain-controlled deformation mode, then it can be readily seen that the percentage change of angular position of the fibrils is of the same order as the fibril strain itself (<xref rid="f0035" ref-type="fig">Fig. 7</xref>A inset i), which is not what is observed. However, if we consider the fibrils to be relatively rigid fibers in a partially ductile interfibrillar matrix which transmits shear <xref rid="bb0100" ref-type="bibr">[20]</xref>, it can be seen (<xref rid="f0035" ref-type="fig">Fig. 7</xref>A inset ii) that while the fibril strain can be small (due to the high axial stiffness of the rigid fiber) the reorientation of the fiber due to the resolved force perpendicular to the fiber can be significant (due to the lower stiffness of the extrafibrillar matrix). It is therefore clear that large percentage reduction in angular width of the fibril distribution, relative to the fibril strain, can be definitely possible in this case, and that the effect will be larger as the stiffness ratio between interfibrillar matrix and fibers increases. With this in mind, it is possible to consider the reduced rate of reorientation in GIOP as a possible alteration of the stiffness ratio between the mineralized fibrils and the extrafibrillar matrix, specifically to a stiffer extrafibrillar matrix and less stiff fibrils. In the absence of a detailed TEM level study of the type in <xref rid="bb0140" ref-type="bibr">[28]</xref>, our discussion is speculative, but the reduced reorientation may indicate that the fibrils in GIOP are less completely mineralized (at the intrafibrillar level) than in WT, or that an excessive mineral deposition occurs outside of the fibrillar compartment.</p><p>We can also link the altered microstructure in <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> mice &#x02013; specifically the demineralized structures (halos) around osteocytes (<xref rid="f0005" ref-type="fig">Fig. 1</xref>B) <xref rid="bb0120" ref-type="bibr">[24]</xref>, the reduced frequency of osteocytes (<xref rid="f0005" ref-type="fig">Fig. 1</xref>, <xref rid="f0015" ref-type="fig">Fig. 3</xref>), and their qualitative shape &#x02013; to the changed fibrillar mechanics and the altered loading environment in the bone tissue of <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> mice. Previous work has found that the geometrical properties and shape of osteocytes lacunae depend on age <xref rid="bb0180" ref-type="bibr">[36]</xref>, anatomical site <xref rid="bb0185" ref-type="bibr">[37]</xref> and collagen fibre arrangement <xref rid="bb0190" ref-type="bibr">[38]</xref>, with more elongated osteocytes in regions of greater collagen fibre alignment and rounder osteocytes in tissues with more random fibre orientation like woven bone. Here, our SAXD results showed that fibrillar orientation of <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> mice is lower (more random) than in WT mice (<xref rid="f0030" ref-type="fig">Fig. 6</xref>E), and also that the fibril modulus is lower (<xref rid="f0030" ref-type="fig">Fig. 6</xref>B). It is therefore likely that this alteration in the collagen fibril orientation and mechanics is linked to the change in osteocyte morphology to a less elongated structure <xref rid="bb0035" ref-type="bibr">[7]</xref>, <xref rid="bb0120" ref-type="bibr">[24]</xref>. The alterations in intracortical porosity will most likely also play a significant role in reduction of mechanical competence, since extrinsic toughening mechanisms like crack bridging and crack deflection depend sensitively on the lamellar structure, orientation and mineralization <xref rid="bb0195" ref-type="bibr">[39]</xref>, <xref rid="bb0200" ref-type="bibr">[40]</xref>.These microstructural alterations may arise by three main mechanisms (i) crack path deflection at the interface between the lower mineralized halos and the surrounding tissue, or crack initiation at the cement lines around the halos, both of which will change the fracture toughness and (ii) a disrupted mechanosensory osteocytic network <xref rid="bb0135" ref-type="bibr">[27]</xref> and to the apoptosis of osteocytes <xref rid="bb0010" ref-type="bibr">[2]</xref>, <xref rid="bb0205" ref-type="bibr">[41]</xref>. <xref rid="f0035" ref-type="fig">Fig. 7</xref> shows some key elements in the alteration of the mineralized matrix in <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> mice, encapsulating the lower mineralization, more extensible and greater randomness of the fibrillar network.</p></sec><sec id="s0075"><label>5</label><title>Conclusion</title><p>In this study we demonstrated that in a mouse model for glucocorticoid-induced osteoporosis, both the fibrillar deformation mechanisms at the nanoscale and the microscale mineralization distribution are significantly altered compared to healthy bone. At the nanometre length scale, we found altered fibrillar deformation (increased extensibility and lower fibril modulus) in <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice bone, as well as less oriented fibrils. At the microscale in <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice, a lower mineral content, increased heterogeneity in mineralization near osteocytes and significant alterations in the three-dimensional mineralized matrix is observed. In contrast, WT bone is more uniformly mineralized as shown by the qBSE results. We propose that the altered deformation mechanisms at the nanoscale &#x02013; increased flexibility, lower fibril modulus, altered fibrillar reorientation &#x02013; in conjunction with altered microstructural toughening mechanisms due to heterogeneous mineralization are critical factors leading to the increased macroscopic fragility in GIOP.</p><p>The following are the supplementary data related to this article.<supplementary-material content-type="local-data" id="ec0005"><caption><p>Supplementary material</p></caption><media xlink:href="mmc1.doc"/></supplementary-material><supplementary-material content-type="local-data" id="ec0010"><caption><title>Video S1</title><p>3D reconstruction of WT tibia mid diaphysis showing vascular network and distribution of osteocyte lacunae.</p></caption><media xlink:href="mmc2.jpg"/></supplementary-material><supplementary-material content-type="local-data" id="ec0015"><caption><title>Video S2</title><p>3D reconstruction of <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> tibia mid diaphysis showing reduced vascular network and disturbed distribution of osteocyte lacunae. Resorption cavities can be observed along the entire length of the bone and they are segmented with red color for better visualization.</p></caption><media xlink:href="mmc3.jpg"/></supplementary-material></p></sec><sec id="s0080"><title>Funding sources</title><p>Medical Research Council UK; Diamond Light Source Ltd., Diamond House, Oxfordshire, UK; School of Engineering and Material Sciences, Queen Mary University of London, London, E1 4NS, UK; Engineering and Physical Research Council (EPSRC) UK, Swindon, UK.</p></sec><sec id="s0085"><title>Disclosure</title><p>The authors state that they have no conflicts of interest.</p></sec><sec id="s0090"><title>Conflict of interest</title><p>All authors have no conflict of interest.</p></sec></body><back><ref-list><title>References</title><ref id="bb0005"><label>1</label><element-citation publication-type="journal" id="rf0005"><person-group person-group-type="author"><name><surname>Van Staa</surname><given-names>T.P.</given-names></name><name><surname>Laan</surname><given-names>R.F.</given-names></name><name><surname>Barton</surname><given-names>I.P.</given-names></name><name><surname>Cohen</surname><given-names>S.</given-names></name><name><surname>Reid</surname><given-names>D.M.</given-names></name><name><surname>Cooper</surname><given-names>C.</given-names></name></person-group><article-title>Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy</article-title><source>Arthritis Rheum.</source><volume>48</volume><year>2003</year><fpage>3224</fpage><lpage>3229</lpage><pub-id pub-id-type="pmid">14613287</pub-id></element-citation></ref><ref id="bb0010"><label>2</label><element-citation publication-type="journal" id="rf0010"><person-group person-group-type="author"><name><surname>Weinstein</surname><given-names>R.S.</given-names></name></person-group><article-title>Glucocorticoid-induced bone disease</article-title><source>N. Engl. J. Med.</source><volume>365</volume><year>2011</year><fpage>62</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">21732837</pub-id></element-citation></ref><ref id="bb0015"><label>3</label><element-citation publication-type="journal" id="rf0015"><person-group person-group-type="author"><name><surname>T&#x000f3;th</surname><given-names>M.</given-names></name><name><surname>Grossman</surname><given-names>A.</given-names></name></person-group><article-title>Glucocorticoid-induced osteoporosis: lessons from Cushing's syndrome</article-title><source>Clin. Endocrinol.</source><volume>79</volume><year>2013</year><fpage>1</fpage><lpage>11</lpage></element-citation></ref><ref id="bb0020"><label>4</label><element-citation publication-type="journal" id="rf0020"><person-group person-group-type="author"><name><surname>Mazziotti</surname><given-names>G.</given-names></name><name><surname>Angeli</surname><given-names>A.</given-names></name><name><surname>Bilezikian</surname><given-names>J.P.</given-names></name><name><surname>Canalis</surname><given-names>E.</given-names></name><name><surname>Giustina</surname><given-names>A.</given-names></name></person-group><article-title>Glucocorticoid-induced osteoporosis: an update</article-title><source>Trends Endocrinol. Metab.</source><volume>17</volume><year>2006</year><fpage>144</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">16678739</pub-id></element-citation></ref><ref id="bb0025"><label>5</label><element-citation publication-type="journal" id="rf0025"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>K.</given-names></name><name><surname>Yamamoto</surname><given-names>M.</given-names></name><name><surname>Murakawa</surname><given-names>Y.</given-names></name><name><surname>Yamauchi</surname><given-names>M.</given-names></name><name><surname>Kaji</surname><given-names>H.</given-names></name><name><surname>Yamaguchi</surname><given-names>T.</given-names></name><name><surname>Sugimoto</surname><given-names>T.</given-names></name></person-group><article-title>Bone fragility in male glucocorticoid-induced osteoporosis is not defined by bone mineral density</article-title><source>Osteoporos. Int.</source><volume>20</volume><year>2009</year><fpage>1889</fpage><lpage>1894</lpage><pub-id pub-id-type="pmid">19387764</pub-id></element-citation></ref><ref id="bb0030"><label>6</label><element-citation publication-type="journal" id="rf0030"><person-group person-group-type="author"><name><surname>Lane</surname><given-names>N.E.</given-names></name><name><surname>Yao</surname><given-names>W.</given-names></name><name><surname>Balooch</surname><given-names>M.</given-names></name><name><surname>Nalla</surname><given-names>R.K.</given-names></name><name><surname>Balooch</surname><given-names>G.</given-names></name><name><surname>Habelitz</surname><given-names>S.</given-names></name><name><surname>Kinney</surname><given-names>J.H.</given-names></name><name><surname>Bonewald</surname><given-names>L.F.</given-names></name></person-group><article-title>Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice</article-title><source>J. Bone Miner. Res.</source><volume>21</volume><year>2006</year><fpage>466</fpage><lpage>476</lpage><pub-id pub-id-type="pmid">16491295</pub-id></element-citation></ref><ref id="bb0035"><label>7</label><element-citation publication-type="journal" id="rf0035"><person-group person-group-type="author"><name><surname>Balooch</surname><given-names>G.</given-names></name><name><surname>Yao</surname><given-names>W.</given-names></name><name><surname>Ager</surname><given-names>J.W.</given-names></name><name><surname>Balooch</surname><given-names>M.</given-names></name><name><surname>Nalla</surname><given-names>R.K.</given-names></name><name><surname>Porter</surname><given-names>A.E.</given-names></name><name><surname>Ritchie</surname><given-names>R.O.</given-names></name><name><surname>Lane</surname><given-names>N.E.</given-names></name></person-group><article-title>The aminobisphosphonate risedronate preserves localized mineral and material properties of bone in the presence of glucocorticoids</article-title><source>Arthritis Rheum.</source><volume>56</volume><year>2007</year><fpage>3726</fpage><lpage>3737</lpage><pub-id pub-id-type="pmid">17968931</pub-id></element-citation></ref><ref id="bb0040"><label>8</label><element-citation publication-type="journal" id="rf0040"><person-group person-group-type="author"><name><surname>Dalle Carbonare</surname><given-names>L.</given-names></name><name><surname>Bertoldo</surname><given-names>F.</given-names></name><name><surname>Valenti</surname><given-names>M.T.</given-names></name><name><surname>Zenari</surname><given-names>S.</given-names></name><name><surname>Zanatta</surname><given-names>M.</given-names></name><name><surname>Sella</surname><given-names>S.</given-names></name><name><surname>Giannini</surname><given-names>S.</given-names></name><name><surname>Cascio</surname><given-names>V.L.</given-names></name></person-group><article-title>Histomorphometric analysis of glucocorticoid-induced osteoporosis</article-title><source>Micron</source><volume>36</volume><year>2005</year><fpage>645</fpage><lpage>652</lpage><pub-id pub-id-type="pmid">16243531</pub-id></element-citation></ref><ref id="bb0045"><label>9</label><element-citation publication-type="journal" id="rf0045"><person-group person-group-type="author"><name><surname>Poundarik</surname><given-names>A.A.</given-names></name><name><surname>Diab</surname><given-names>T.</given-names></name><name><surname>Sroga</surname><given-names>G.E.</given-names></name><name><surname>Ural</surname><given-names>A.</given-names></name><name><surname>Boskey</surname><given-names>A.L.</given-names></name><name><surname>Gundberg</surname><given-names>C.M.</given-names></name><name><surname>Vashishth</surname><given-names>D.</given-names></name></person-group><article-title>Dilatational band formation in bone</article-title><source>Proc. Natl. Acad. Sci.</source><volume>109</volume><year>2012</year><fpage>19178</fpage><lpage>19183</lpage><pub-id pub-id-type="pmid">23129653</pub-id></element-citation></ref><ref id="bb0050"><label>10</label><element-citation publication-type="journal" id="rf0050"><person-group person-group-type="author"><name><surname>Zimmermann</surname><given-names>E.A.</given-names></name><name><surname>Schaible</surname><given-names>E.</given-names></name><name><surname>Bale</surname><given-names>H.</given-names></name><name><surname>Barth</surname><given-names>H.D.</given-names></name><name><surname>Tang</surname><given-names>S.Y.</given-names></name><name><surname>Reichert</surname><given-names>P.</given-names></name><name><surname>Busse</surname><given-names>B.</given-names></name><name><surname>Alliston</surname><given-names>T.</given-names></name><name><surname>Ager</surname><given-names>J.W.</given-names><suffix>3rd</suffix></name><name><surname>Ritchie</surname><given-names>R.O.</given-names></name></person-group><article-title>Age-related changes in the plasticity and toughness of human cortical bone at multiple length scales</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><year>2011</year></element-citation></ref><ref id="bb0055"><label>11</label><element-citation publication-type="journal" id="rf0055"><person-group person-group-type="author"><name><surname>Fratzl</surname><given-names>P.</given-names></name><name><surname>Weinkamer</surname><given-names>R.</given-names></name></person-group><article-title>Nature's hierarchical materials</article-title><source>Prog. Mater. Sci.</source><volume>52</volume><year>2007</year><fpage>1263</fpage><lpage>1334</lpage></element-citation></ref><ref id="bb0060"><label>12</label><element-citation publication-type="journal" id="rf0060"><person-group person-group-type="author"><name><surname>Meyers</surname><given-names>M.A.</given-names></name><name><surname>Chen</surname><given-names>P.Y.</given-names></name><name><surname>Lin</surname><given-names>A.Y.M.</given-names></name><name><surname>Seki</surname><given-names>Y.</given-names></name></person-group><article-title>Biological materials: structure and mechanical properties</article-title><source>Prog. Mater. Sci.</source><volume>53</volume><year>2008</year><fpage>1</fpage><lpage>206</lpage></element-citation></ref><ref id="bb0065"><label>13</label><element-citation publication-type="journal" id="rf0065"><person-group person-group-type="author"><name><surname>Bentley</surname><given-names>L.</given-names></name><name><surname>Esapa</surname><given-names>C.T.</given-names></name><name><surname>Nesbit</surname><given-names>M.A.</given-names></name><name><surname>Head</surname><given-names>R.A.</given-names></name><name><surname>Evans</surname><given-names>H.</given-names></name><name><surname>Lath</surname><given-names>D.</given-names></name><name><surname>Scudamore</surname><given-names>C.L.</given-names></name><name><surname>Hough</surname><given-names>T.A.</given-names></name><name><surname>Podrini</surname><given-names>C.</given-names></name><name><surname>Hannan</surname><given-names>F.M.</given-names></name><name><surname>Fraser</surname><given-names>W.D.</given-names></name><name><surname>Croucher</surname><given-names>P.I.</given-names></name><name><surname>Brown</surname><given-names>M.A.</given-names></name><name><surname>Brown</surname><given-names>S.D.</given-names></name><name><surname>Cox</surname><given-names>R.D.</given-names></name><name><surname>Thakker</surname><given-names>R.V.</given-names></name></person-group><article-title>An N-ethyl-N-nitrosourea induced corticotropin-releasing hormone promoter mutation provides a mouse model for endogenous glucocorticoid excess</article-title><source>Endocrinology</source><volume>155</volume><year>2014</year><fpage>908</fpage><lpage>922</lpage><pub-id pub-id-type="pmid">24302625</pub-id></element-citation></ref><ref id="bb0070"><label>14</label><element-citation publication-type="journal" id="rf0070"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>H.S.</given-names></name><name><surname>Wagermaier</surname><given-names>W.</given-names></name><name><surname>Zickler</surname><given-names>G.A.</given-names></name><name><surname>Aroush</surname><given-names>D.R.B.</given-names></name><name><surname>Funari</surname><given-names>S.S.</given-names></name><name><surname>Roschger</surname><given-names>P.</given-names></name><name><surname>Wagner</surname><given-names>H.D.</given-names></name><name><surname>Fratzl</surname><given-names>P.</given-names></name></person-group><article-title>Nanoscale deformation mechanisms in bone</article-title><source>Nano Lett.</source><volume>5</volume><issue>10</issue><year>2005</year><fpage>2108</fpage><lpage>2111</lpage><pub-id pub-id-type="pmid">16218747</pub-id></element-citation></ref><ref id="bb0075"><label>15</label><element-citation publication-type="journal" id="rf0075"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>H.S.</given-names></name><name><surname>Seto</surname><given-names>J.</given-names></name><name><surname>Wagermaier</surname><given-names>W.</given-names></name><name><surname>Zaslansky</surname><given-names>P.</given-names></name><name><surname>Boesecke</surname><given-names>P.</given-names></name><name><surname>Fratzl</surname><given-names>P.</given-names></name></person-group><article-title>Cooperative deformation of mineral and collagen in bone at the nanoscale</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>103</volume><year>2006</year><fpage>17741</fpage><lpage>17746</lpage><pub-id pub-id-type="pmid">17095608</pub-id></element-citation></ref><ref id="bb0080"><label>16</label><element-citation publication-type="journal" id="rf0080"><person-group person-group-type="author"><name><surname>Karunaratne</surname><given-names>A.</given-names></name><name><surname>Boyde</surname><given-names>A.</given-names></name><name><surname>Esapa</surname><given-names>C.T.</given-names></name><name><surname>Hiller</surname><given-names>J.</given-names></name><name><surname>Terrill</surname><given-names>N.J.</given-names></name><name><surname>Brown</surname><given-names>S.D.M.</given-names></name><name><surname>Cox</surname><given-names>R.D.</given-names></name><name><surname>Thakker</surname><given-names>R.V.</given-names></name><name><surname>Gupta</surname><given-names>H.S.</given-names></name></person-group><article-title>Symmetrically reduced stiffness and increased extensibility in compression and tension at the mineralized fibrillar level in rachitic bone</article-title><source>Bone</source><volume>52</volume><year>2013</year><fpage>689</fpage><lpage>698</lpage><pub-id pub-id-type="pmid">23128355</pub-id></element-citation></ref><ref id="bb0085"><label>17</label><element-citation publication-type="journal" id="rf0085"><person-group person-group-type="author"><name><surname>Karunaratne</surname><given-names>A.</given-names></name><name><surname>Esapa</surname><given-names>C.R.</given-names></name><name><surname>Hiller</surname><given-names>J.</given-names></name><name><surname>Boyde</surname><given-names>A.</given-names></name><name><surname>Head</surname><given-names>R.</given-names></name><name><surname>Bassett</surname><given-names>J.H.D.</given-names></name><name><surname>Terrill</surname><given-names>N.J.</given-names></name><name><surname>Williams</surname><given-names>G.R.</given-names></name><name><surname>Brown</surname><given-names>M.A.</given-names></name><name><surname>Croucher</surname><given-names>P.I.</given-names></name><name><surname>Brown</surname><given-names>S.D.M.</given-names></name><name><surname>Cox</surname><given-names>R.D.</given-names></name><name><surname>Barber</surname><given-names>A.H.</given-names></name><name><surname>Thakker</surname><given-names>R.V.</given-names></name><name><surname>Gupta</surname><given-names>H.S.</given-names></name></person-group><article-title>Significant deterioration in nanomechanical quality occurs through incomplete extrafibrillar mineralization in rachitic bone: evidence from in-situ synchrotron X-ray scattering and backscattered electron imaging</article-title><source>J. Bone Miner. Res.</source><volume>27</volume><year>2012</year><fpage>876</fpage><lpage>890</lpage><pub-id pub-id-type="pmid">22161748</pub-id></element-citation></ref><ref id="bb0090"><label>18</label><element-citation publication-type="journal" id="rf0090"><person-group person-group-type="author"><name><surname>Roschger</surname><given-names>P.</given-names></name><name><surname>Paschalis</surname><given-names>E.P.</given-names></name><name><surname>Fratzl</surname><given-names>P.</given-names></name><name><surname>Klaushofer</surname><given-names>K.</given-names></name></person-group><article-title>Bone mineralization density distribution in health and disease</article-title><source>Bone</source><volume>42</volume><year>2008</year><fpage>456</fpage><lpage>466</lpage><pub-id pub-id-type="pmid">18096457</pub-id></element-citation></ref><ref id="bb0095"><label>19</label><element-citation publication-type="journal" id="rf0095"><person-group person-group-type="author"><name><surname>Barth</surname><given-names>H.D.</given-names></name><name><surname>Launey</surname><given-names>M.E.</given-names></name><name><surname>MacDowell</surname><given-names>A.A.</given-names></name><name><surname>Ager</surname><given-names>J.W.</given-names></name><name><surname>Ritchie</surname><given-names>R.O.</given-names></name></person-group><article-title>On the effect of X-ray irradiation on the deformation and fracture behavior of human cortical bone</article-title><source>Bone</source><volume>46</volume><year>2010</year><fpage>1475</fpage><lpage>1485</lpage><pub-id pub-id-type="pmid">20206724</pub-id></element-citation></ref><ref id="bb0100"><label>20</label><element-citation publication-type="journal" id="rf0100"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>H.S.</given-names></name><name><surname>Krauss</surname><given-names>S.</given-names></name><name><surname>Kerschnitzki</surname><given-names>M.</given-names></name><name><surname>Karunaratne</surname><given-names>A.</given-names></name><name><surname>Dunlop</surname><given-names>J.W.</given-names></name><name><surname>Barber</surname><given-names>A.H.</given-names></name><name><surname>Boesecke</surname><given-names>P.</given-names></name><name><surname>Funari</surname><given-names>S.S.</given-names></name><name><surname>Fratzl</surname><given-names>P.</given-names></name></person-group><article-title>Intrafibrillar plasticity through mineral/collagen sliding is the dominant mechanism for the extreme toughness of antler bone</article-title><source>J. Mech. Behav. Biomed. Mater.</source><volume>28</volume><year>2013</year><fpage>366</fpage><lpage>382</lpage><pub-id pub-id-type="pmid">23707600</pub-id></element-citation></ref><ref id="bb0105"><label>21</label><element-citation publication-type="journal" id="rf0105"><person-group person-group-type="author"><name><surname>Bouvard</surname><given-names>B.</given-names></name><name><surname>Audran</surname><given-names>M.</given-names></name><name><surname>Legrand</surname><given-names>E.</given-names></name><name><surname>Chappard</surname><given-names>D.</given-names></name></person-group><article-title>Ultrastructural characteristics of glucocorticoid-induced osteoporosis</article-title><source>Osteoporos. Int.</source><volume>20</volume><year>2009</year><fpage>1089</fpage><lpage>1092</lpage><pub-id pub-id-type="pmid">19340501</pub-id></element-citation></ref><ref id="bb0110"><label>22</label><element-citation publication-type="journal" id="rf0110"><person-group person-group-type="author"><name><surname>Chappard</surname><given-names>D.</given-names></name><name><surname>Legrand</surname><given-names>E.</given-names></name><name><surname>Basle</surname><given-names>M.F.</given-names></name><name><surname>Fromont</surname><given-names>P.</given-names></name><name><surname>Racineux</surname><given-names>J.L.</given-names></name><name><surname>Rebel</surname><given-names>A.</given-names></name><name><surname>Audran</surname><given-names>M.</given-names></name></person-group><article-title>Altered trabecular architecture induced by corticosteroids: a bone histomorphometric study</article-title><source>J. Bone Miner. Res.</source><volume>11</volume><year>1996</year><fpage>676</fpage><lpage>685</lpage><pub-id pub-id-type="pmid">9157783</pub-id></element-citation></ref><ref id="bb0115"><label>23</label><element-citation publication-type="journal" id="rf0115"><person-group person-group-type="author"><name><surname>Saag</surname><given-names>K.G.</given-names></name><name><surname>Emkey</surname><given-names>R.</given-names></name><name><surname>Schnitzer</surname><given-names>T.J.</given-names></name><name><surname>Brown</surname><given-names>J.P.</given-names></name><name><surname>Hawkins</surname><given-names>F.</given-names></name><name><surname>Goemaere</surname><given-names>S.</given-names></name><name><surname>Thamsborg</surname><given-names>G.</given-names></name><name><surname>Liberman</surname><given-names>U.A.</given-names></name><name><surname>Delmas</surname><given-names>P.D.</given-names></name><name><surname>Malice</surname><given-names>M.P.</given-names></name><name><surname>Czachur</surname><given-names>M.</given-names></name><name><surname>Daifotis</surname><given-names>A.G.</given-names></name><name><surname>Interven</surname><given-names>G.-I.O.</given-names></name></person-group><article-title>Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis</article-title><source>N. Engl. J. Med.</source><volume>339</volume><year>1998</year><fpage>292</fpage><lpage>299</lpage><pub-id pub-id-type="pmid">9682041</pub-id></element-citation></ref><ref id="bb0120"><label>24</label><element-citation publication-type="journal" id="rf0120"><person-group person-group-type="author"><name><surname>Lane</surname><given-names>N.E.</given-names></name><name><surname>Yao</surname><given-names>W.</given-names></name></person-group><article-title>Glucocorticoid-induced bone fragility</article-title><source>Ann. N. Y. Acad. Sci.</source><volume>1192</volume><year>2010</year><fpage>81</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">20392221</pub-id></element-citation></ref><ref id="bb0125"><label>25</label><element-citation publication-type="journal" id="rf0125"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>W.</given-names></name><name><surname>Cheng</surname><given-names>Z.</given-names></name><name><surname>Pham</surname><given-names>A.</given-names></name><name><surname>Busse</surname><given-names>C.</given-names></name><name><surname>Zimmermann</surname><given-names>E.A.</given-names></name><name><surname>Ritchie</surname><given-names>R.O.</given-names></name><name><surname>Lane</surname><given-names>N.E.</given-names></name></person-group><article-title>Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization</article-title><source>Arthritis Rheum.</source><volume>58</volume><year>2008</year><fpage>3485</fpage><lpage>3497</lpage><pub-id pub-id-type="pmid">18975341</pub-id></element-citation></ref><ref id="bb0130"><label>26</label><element-citation publication-type="journal" id="rf0130"><person-group person-group-type="author"><name><surname>Canalis</surname><given-names>E.</given-names></name><name><surname>Mazziotti</surname><given-names>G.</given-names></name><name><surname>Giustina</surname><given-names>A.</given-names></name><name><surname>Bilezikian</surname><given-names>J.</given-names></name></person-group><article-title>Glucocorticoid-induced osteoporosis: pathophysiology and therapy</article-title><source>Osteoporos. Int.</source><volume>18</volume><year>2007</year><fpage>1319</fpage><lpage>1328</lpage><pub-id pub-id-type="pmid">17566815</pub-id></element-citation></ref><ref id="bb0135"><label>27</label><element-citation publication-type="journal" id="rf0135"><person-group person-group-type="author"><name><surname>Bonewald</surname><given-names>L.F.</given-names></name><name><surname>Johnson</surname><given-names>M.L.</given-names></name></person-group><article-title>Osteocytes, mechanosensing and Wnt signaling</article-title><source>Bone</source><volume>42</volume><year>2008</year><fpage>606</fpage><lpage>615</lpage><pub-id pub-id-type="pmid">18280232</pub-id></element-citation></ref><ref id="bb0140"><label>28</label><element-citation publication-type="journal" id="rf0140"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>B.</given-names></name><name><surname>Daulton</surname><given-names>T.L.</given-names></name><name><surname>Genin</surname><given-names>G.M.</given-names></name><name><surname>Lipner</surname><given-names>J.</given-names></name><name><surname>Pasteris</surname><given-names>J.D.</given-names></name><name><surname>Wopenka</surname><given-names>B.</given-names></name><name><surname>Thomopoulos</surname><given-names>S.</given-names></name></person-group><article-title>The nanometre-scale physiology of bone: steric modelling and scanning transmission electron microscopy of collagen-mineral structure</article-title><source>J. R. Soc. Interface</source><volume>9</volume><year>2012</year><fpage>1774</fpage><lpage>1786</lpage><pub-id pub-id-type="pmid">22345156</pub-id></element-citation></ref><ref id="bb0145"><label>29</label><element-citation publication-type="journal" id="rf0145"><person-group person-group-type="author"><name><surname>Weinstein</surname><given-names>R.S.</given-names></name><name><surname>Chen</surname><given-names>J.R.</given-names></name><name><surname>Powers</surname><given-names>C.C.</given-names></name><name><surname>Stewart</surname><given-names>S.A.</given-names></name><name><surname>Landes</surname><given-names>R.D.</given-names></name><name><surname>Bellido</surname><given-names>T.</given-names></name><name><surname>Jilka</surname><given-names>R.L.</given-names></name><name><surname>Parfitt</surname><given-names>A.M.</given-names></name><name><surname>Manolagas</surname><given-names>S.C.</given-names></name></person-group><article-title>Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids</article-title><source>J. Clin. Investig.</source><volume>109</volume><year>2002</year><fpage>1041</fpage><lpage>1048</lpage><pub-id pub-id-type="pmid">11956241</pub-id></element-citation></ref><ref id="bb0150"><label>30</label><element-citation publication-type="journal" id="rf0150"><person-group person-group-type="author"><name><surname>Heuck</surname><given-names>F.</given-names></name></person-group><article-title>Comparative investigations of the function of osteocytes in bone resorption</article-title><source>Calcif. Tissue Res.</source><volume>Suppl.</volume><year>1970</year><fpage>148</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">5427962</pub-id></element-citation></ref><ref id="bb0155"><label>31</label><element-citation publication-type="journal" id="rf0155"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>W.</given-names></name><name><surname>Dai</surname><given-names>W.</given-names></name><name><surname>Jiang</surname><given-names>J.X.</given-names></name><name><surname>Lane</surname><given-names>N.E.</given-names></name></person-group><article-title>Glucocorticoids and osteocyte autophagy</article-title><source>Bone</source><volume>54</volume><year>2013</year><fpage>279</fpage><lpage>284</lpage><pub-id pub-id-type="pmid">23356984</pub-id></element-citation></ref><ref id="bb0160"><label>32</label><element-citation publication-type="journal" id="rf0160"><person-group person-group-type="author"><name><surname>Bonewald</surname><given-names>L.F.</given-names></name></person-group><article-title>The amazing osteocyte</article-title><source>J. Bone Miner. Res.</source><volume>26</volume><year>2011</year><fpage>229</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">21254230</pub-id></element-citation></ref><ref id="bb0165"><label>33</label><element-citation publication-type="journal" id="rf0165"><person-group person-group-type="author"><name><surname>Boyde</surname><given-names>A.</given-names></name></person-group><article-title>Evidence against osteocytic osteolysis</article-title><source>Metab. Bone Dis. Relat. Res.</source><volume>2S</volume><year>1980</year><fpage>17</fpage></element-citation></ref><ref id="bb0170"><label>34</label><element-citation publication-type="journal" id="rf0170"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>H.</given-names></name><name><surname>Wagermaier</surname><given-names>W.</given-names></name><name><surname>Zickler</surname><given-names>G.</given-names></name><name><surname>Hartmann</surname><given-names>J.</given-names></name><name><surname>Funari</surname><given-names>S.</given-names></name><name><surname>Roschger</surname><given-names>P.</given-names></name><name><surname>Wagner</surname><given-names>H.</given-names></name><name><surname>Fratzl</surname><given-names>P.</given-names></name></person-group><article-title>Fibrillar level fracture in bone beyond the yield point</article-title><source>Int. J. Fract.</source><volume>139</volume><year>2006</year><fpage>425</fpage><lpage>436</lpage></element-citation></ref><ref id="bb0175"><label>35</label><element-citation publication-type="journal" id="rf0175"><person-group person-group-type="author"><name><surname>Granke</surname><given-names>M.</given-names></name><name><surname>Gourrier</surname><given-names>A.</given-names></name><name><surname>Rupin</surname><given-names>F.</given-names></name><name><surname>Raum</surname><given-names>K.</given-names></name><name><surname>Peyrin</surname><given-names>F.</given-names></name><name><surname>Burghammer</surname><given-names>M.</given-names></name><name><surname>Sa&#x000ef;ed</surname><given-names>A.</given-names></name><name><surname>Laugier</surname><given-names>P.</given-names></name></person-group><article-title>Microfibril orientation dominates the microelastic properties of human bone tissue at the lamellar length scale</article-title><source>PLoS One</source><volume>8</volume><year>2013</year><object-id pub-id-type="publisher-id">e58043</object-id></element-citation></ref><ref id="bb0180"><label>36</label><element-citation publication-type="journal" id="rf0180"><person-group person-group-type="author"><name><surname>Hirose</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Kojima</surname><given-names>T.</given-names></name><name><surname>de Freitas</surname><given-names>P.H.L.</given-names></name><name><surname>Ubaidus</surname><given-names>S.</given-names></name><name><surname>Oda</surname><given-names>K.</given-names></name><name><surname>Saito</surname><given-names>C.</given-names></name><name><surname>Amizuka</surname><given-names>N.</given-names></name></person-group><article-title>A histological assessment on the distribution of the osteocytic lacunar canalicular system using silver staining</article-title><source>J. Bone Miner. Metab.</source><volume>25</volume><year>2007</year><fpage>374</fpage><lpage>382</lpage><pub-id pub-id-type="pmid">17968489</pub-id></element-citation></ref><ref id="bb0185"><label>37</label><element-citation publication-type="journal" id="rf0185"><person-group person-group-type="author"><name><surname>Vatsa</surname><given-names>A.</given-names></name><name><surname>Breuls</surname><given-names>R.G.</given-names></name><name><surname>Semeins</surname><given-names>C.M.</given-names></name><name><surname>Salmon</surname><given-names>P.L.</given-names></name><name><surname>Smit</surname><given-names>T.H.</given-names></name><name><surname>Klein-Nulend</surname><given-names>J.</given-names></name></person-group><article-title>Osteocytemorphology in fibula and calvaria &#x02014; Is there a role for mechanosensing?</article-title><source>Bone</source><volume>43</volume><year>2008</year><fpage>452</fpage><lpage>458</lpage><pub-id pub-id-type="pmid">18625577</pub-id></element-citation></ref><ref id="bb0190"><label>38</label><element-citation publication-type="journal" id="rf1185"><person-group person-group-type="author"><name><surname>Remaggi</surname><given-names>F.</given-names></name><name><surname>Cane</surname><given-names>V.</given-names></name><name><surname>Palumbo</surname><given-names>C.</given-names></name><name><surname>Ferretti</surname><given-names>M.</given-names></name></person-group><article-title>Histomorphometric study on the osteocyte lacuno-canalicular network in animals of different species. I. Woven-fibered and parallel-fibered bones</article-title><source>Ital. J. Anat. Embryol.</source><volume>103</volume><year>1998</year><fpage>145</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">9882957</pub-id></element-citation></ref><ref id="bb0195"><label>39</label><element-citation publication-type="journal" id="rf0190"><person-group person-group-type="author"><name><surname>Reilly</surname><given-names>G.C.</given-names></name></person-group><article-title>Observations of microdamage around osteocyte lacunae in bone</article-title><source>J. Biomech.</source><volume>33</volume><year>2000</year><fpage>1131</fpage><lpage>1134</lpage><pub-id pub-id-type="pmid">10854886</pub-id></element-citation></ref><ref id="bb0200"><label>40</label><element-citation publication-type="journal" id="rf0195"><person-group person-group-type="author"><name><surname>Reilly</surname><given-names>G.C.</given-names></name><name><surname>Currey</surname><given-names>J.D.</given-names></name></person-group><article-title>The effects of damage and microcracking on the impact strength of bone</article-title><source>J. Biomech.</source><volume>33</volume><year>2000</year><fpage>337</fpage><lpage>343</lpage><pub-id pub-id-type="pmid">10673117</pub-id></element-citation></ref><ref id="bb0205"><label>41</label><element-citation publication-type="journal" id="rf0200"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>P.</given-names></name><name><surname>Meier</surname><given-names>M.</given-names></name><name><surname>Wepf</surname><given-names>R.</given-names></name><name><surname>Muller</surname><given-names>R.</given-names></name></person-group><article-title>Towards quantitative 3D imaging of the osteocyte lacuno-canalicular network</article-title><source>Bone</source><volume>47</volume><year>2010</year><fpage>848</fpage><lpage>858</lpage><pub-id pub-id-type="pmid">20691297</pub-id></element-citation></ref></ref-list><ack id="ac0005"><title>Acknowledgements</title><p>The authors thank the <funding-source id="gts0005">Medical Research Council</funding-source> for funding (G0600702). AK acknowledges <funding-source id="gts0010">Diamond Light Source and Queen Mary University of London</funding-source> for funding ((MATL1D8R and CDTA SEM7100b). XL thanks the <funding-source id="gts0015">China Scholarship Council and Diamond Light Source</funding-source> for funding (SEML1B4R).</p></ack></back><floats-group><fig id="f0005"><label>Fig. 1</label><caption><p>Backscattered scanning electron microscopy images collected from the mid shaft (transverse cross section) of the cortical bone of the WT (A) and <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice (B). Top images are full transverse cross section and areas surrounded by white dash lines represent cross section of mechanically tested sample. Higher magnification BSE images shown in the bottom panel are obtained from the anterior regions (white squares in top images) of the cortex. In <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> bone two distinct regions were observed. Dark gray sections (i) surrounded by white bands (cement lines) were observed near cavities in <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> bone and (ii) periosteal cortex (no cavities) were observed areas (50&#x000a0;&#x000d7;&#x000a0;50&#x000a0;&#x003bc;m) surrounded by black squares (i and ii) in bottom panel of A and B were used for quantification of mineralization parameters.</p></caption><graphic xlink:href="gr1"/></fig><fig id="f0010"><label>Fig. 2</label><caption><p>Quantitative backscattered scanning electron microscopy. (A) Bone mineral density distribution (BMDD) was produced for WT (black) <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> non-haloes (light gray) and <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> halo (dark gray). (B, C) Ca<sub>mean</sub> (representing average mineral content) and FWHM (representing local variation of mineral content) calculated from BMDD and plotted for WT (black) and <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> non-haloes (gray) and halos (dark gray). Errors shown are standard deviations. One way ANOVA test results showed three groups were significantly different for Ca<sub>mean</sub> and FWHM measurements. The post-hoc test (Tukey HSD test) was performed subsequently to identify which of the pairs of treatments are significantly different from each other. Pair-wise brackets denote statistical significance (**<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01, ***<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.001, ns: not significant).</p></caption><graphic xlink:href="gr2"/></fig><fig id="f0015"><label>Fig. 3</label><caption><p>Synchrotron X-ray microCT transverse images (A) and 3D reconstructions (B, C and D) of WT (left) and <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> (right) tibiae mid diaphysis of three specimens. (A) Transverse SR CT sections (B) top view of 3D reconstructions of cavities (red), inner cortico-endosteal tissue (purple), canal and lacunae network (yellow) (C) Isometric projections of 3D reconstructions (transparency of canal and lacunae is set to 0.75) shows cavities and inner cortico-endosteal tissue in <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> specimens and higher number of canals and lacunae can be observed in WT tibiae than <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> bone (D) 3D reconstruction of cortico-endosteal pores and inner cortico-endosteal tissue can be only seen in <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup>. Volume fractions for cavities and inner cortico-endosteal tissue are given for <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> (transparency for canal and lacunae are set to 1).</p></caption><graphic xlink:href="gr3"/></fig><fig id="f0020"><label>Fig. 4</label><caption><p>Morphometric analysis Synchrotron X-ray micro-computed tomography results (A) The canal network was characterized by the canal number density. (B) Measures for the lacunar system included the lacunar number density. Error bars are standard deviations. Student's t tests were used to compare canal density and lacunae density between wild-type and <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice. Pairwise brackets denote statistical significance (*<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05, ***<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.001).</p></caption><graphic xlink:href="gr4"/></fig><fig id="f0025"><label>Fig. 5</label><caption><p>Macro&#x000a0;mechanical testing results. (A) Stress vs. measured tissue strain % for WT (n&#x000a0;=&#x000a0;4/filled symbols) and <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> (n&#x000a0;=&#x000a0;6/open symbols) mice for each sample. Solid lines are average regression lines for wild-type (black) and <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> (grey). Average tissue modulus &#x003c3;/&#x003b5;<sub>T</sub> showing in inset. (B) Maximum stress and (C) maximum tissue strain plotted for WT (black) and <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> (grey) mice. Error bars are standard deviations. Student's t tests were used to compare elastic moduli, maximum stress and maximum strain between wild-type and <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> mice. Pairwise brackets denote statistical significance (*<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05, ns&#x000a0;=&#x000a0;not significant).</p></caption><graphic xlink:href="gr5"/></fig><fig id="f0030"><label>Fig. 6</label><caption><p>In-situ nano-mechanical and fibrillar orientation results. (A) Stress vs. fibril strain % for WT (n&#x000a0;=&#x000a0;4/filled symbols) and <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> (n&#x000a0;=&#x000a0;6/open symbols) (solid lines &#x02014; r<sup>2</sup> WT&#x000a0;=&#x000a0;0.98 and r<sup>2</sup><italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup>&#x000a0;=&#x000a0;0.95). (B) Effective fibril modulus &#x003c3;/&#x003b5;<sub>F</sub> plotted for elastic region of WT (black) and <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> mice (grey). (C) Fibril strain (&#x003b5;<sub>F</sub>) % vs. tissue strain (&#x003b5;<sub>T</sub>) % as a function of disease state WT (filled symbols) and <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> (open symbols) mice (solid lines &#x02014; r<sup>2</sup> WT&#x000a0;=&#x000a0;0.88 and r<sup>2</sup><italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup>&#x000a0;=&#x000a0;0.87). (D) Average fibril strain to tissue strain ratio (&#x003b5;<sub>F</sub>/&#x003b5;<sub>T</sub>) plotted for elastic region of WT (black) and <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> mice (grey) (E) Change in fibril orientation (%) with loading vs. tissue strain (&#x003b5;<sub>T</sub>) % as a function of disease state WT (filled symbols) and <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> (open symbols) mice (solid lines &#x02014; r<sup>2</sup> WT&#x000a0;=&#x000a0;0. 96 and r<sup>2</sup><italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup>&#x000a0;=&#x000a0;0.82) Average rate of collagen fibrillar reorientation showing in inset. (F) Full width at half maximum of intensity distribution of the 3rd order fibril reflection was plotted for WT (filled symbols) and <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> (open symbols). Large symbols are average FWHM values and small symbols are individual data points. For A, C and E dash lines (WT&#x000a0;=&#x000a0;black and <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup>&#x000a0;=&#x000a0;grey) are regression lines for each specimen. Solid lines are average regression lines for WT (black) and <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> (grey) of all test samples in each disease state. For B, D, E and F error bars are standard deviations. Student t-tests were used to compare fibril moduli, strain ratio, maximum fibril strain, rate of collagen fibrillar reorientation and FWHM between WT and <italic>Crh</italic><sup><italic>&#x02212;</italic>&#x000a0;120/+</sup> mice. Pair-wise brackets denote statistical significance (*<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05, **<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01, ***<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.001, ns: not significant).</p></caption><graphic xlink:href="gr6"/></fig><fig id="f0035"><label>Fig. 7</label><caption><p>(A) Bone specimen mounted on tensile testing grips. Tissue (macro) level measurements were taken on a 5&#x000a0;mm long bone specimen. SAXD measurements were obtained from mineralized collagen fibrils at nano meter scale. (i) Strain controlled fibril reorientation&#x02013;fibril reorientation for a measured localized tissue strain is &#x003b4;&#x003b8;<sub>(strain)</sub>. (ii) Stress controlled fibril reorientation&#x02013;fibril reorientation for a measured localized tissue strain is &#x003b4;&#x003b8;<sub>(stress).</sub> In this experiment fibril reorientation is occurred locally on the interrogated point on the sample, local stress-control instead of strain control (arrows on inset (i) and (ii) denotes fibril direction on tensile specimen. (B) Schematic representation of the bone matrix in WT and <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> conditions at the microscale and nanoscale. As our qBSE results only provide experimental information at the micrometre length scale, hence schematic was drawn with an osteocyte (10 to 15&#x000a0;&#x003bc;m) and several fibre bundles (5 to 10&#x000a0;&#x003bc;m). In WT mice, fiber bundles are fully mineralized, whereas <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> bone has micro pores and less mineralized. These less well mineralized structures are more localized around the osteocytes. At the fibrillar level we speculate that collagen fibrils are partly mineralized along the length of the fibril in the <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> condition. At this level, the WT mineralized collagen fibrils are fully covered with mineral. However, the mineralized fibrils from the <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> halo regions are partly mineralized (extra and/or intra) and less orientated. These structural alterations in <italic>Crh</italic><sup>&#x02212;&#x000a0;120/+</sup> could be explained by the nano mechanical data obtained in this study.</p></caption><graphic xlink:href="gr7"/></fig></floats-group></article>